Bookmark and Share
LYPLA1 (geneid:10434) - Gene BioActivity Data
Also known as: APT-1, APT1, LPL-I, LPL1, hAPT1.
BioActivity Outcomes:
Probe(2)
 
 
Active(874)
 
 
Inactive(314874)
 
 
Unspecified(4)
 
 
BioAssay Types:
Screening(315580)
 
 
 
Confirmatory(13)
 
 
 
 
Literature(6)
 
 
Summary(2)
 
 
BioActivity Types:
IC50(4)
 
 
 
 
Ki(1)
 
 
Substance Types:
Chemical(315746)
 
 
 
 
 
RNAi(8)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 26    Data Row: 315754   Total Pages: 15788   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID99445332]
[CID71304779]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
2
[SID99445338]
[CID56593118]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
3
[SID124968799]
[CID45100481]
IC50 0.0054Inhibition of APT1 (unknown origin) [AID1079563, Type: confirmatory] [gi:41017274]
View
4
[SID164117611]
[CID71710938]
0.087Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in situ [AID743119_1, Type: confirmatory] [gi:5453722]
View
5
[SID164117614]
[CID71710927]
0.092Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
6
[SID164117611]
[CID71710938]
0.122Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
7
[SID164117604]
[CID71710942]
0.154Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
8
[SID160654487]
[CID3238952]
0.21Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP [AID651990_1, Type: confirmatory] [gi:5453722]
View
9
[SID164117610]
[CID71710929]
0.225Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
10
[SID103711314]
[CID3238952]
Ki 0.3Inhibition of APT1 (unknown origin) by FluPol-ABPP assay [AID1079554, Type: confirmatory] [gi:41017274]
View
11
[SID164117613]
[CID71710939]
0.306Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
12
[SID164117611]
[CID71710938]
Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP gel filtration assay to assess inhibitor binding mode [AID743133_1, Type: other] [gi:5453722]
View
13
[SID164117611]
[CID71710938]
Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP gel filtration assay to assess inhibitor binding mode [AID743133_2, Type: other] [gi:5453722]
View
14
[SID164117611]
[CID71710938]
Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: LCMS-based cell-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis [AID743137_1, Type: other] [gi:5453722]
View
15
[SID160709349]
[CID70697691]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
16
[SID160709335]
[CID70697702]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
17
[SID160709341]
[CID70697705]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
18
[SID160709342]
[CID70697695]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in vitro, Set 2 [AID652018_1, Type: other] [gi:5453722]
View
19
[SID160654486]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1: LCMS-based cell-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis in situ [AID651979_1, Type: other] [gi:5453722]
View
20
[SID160654486]
[CID3238952]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID651988_1, Type: other] [gi:5453722]
View